Kim Kardashian will probably think twice next time she considers asking her 42 million Instagram followers to double-tap her prescription drug endorsements. The Food and Drug Administration sent a letter to the makers of Diclegis (a morning sickness drug she promoted last month) asking them to “stop ‘misbranding’ the drug or take it off the market.”
By “misbranding,” I think they mean “asking famous contoured faces to be photographed with their product under harsh lighting.”
The problem ... Kim sings the virtues but not the risks of the drug ... something the FDA requires. The letter demands the company correct the problem by getting Kim to repost her endorsements with the proper warnings.
A rep for Diclegis also confirmed that, yes, Kim was paid for the post—but only the one time.
Imagine if Kim started posting images with captions like this:
Contact the author at email@example.com.
Image via Instagram. Risks via Dicelgis.